BUZZ - Pharmaceutical company Liquidia surges after reaching a settlement with United Therapeutics

October 14 - ** The share price of pharmaceutical company Liquidia (LQDA.O) soared by 46.21% in pre-market trading, reaching $39.20

** The company stated that it has reached a settlement with United Therapeutics (UTHR.O) regarding all six pending lawsuits, ensuring that the supply of the drug YUTREPIA for patients with a certain type of pulmonary arterial hypertension remains unaffected

** The company will make phased payments totaling a net amount of $380.7 million until 2027 to resolve the lawsuits

** As of the close of the previous trading day, the share had declined by more than 22% year-to-date

(To facilitate non-native English speakers, Reuters provides automated translations of its reports in several languages. Since automated translations may contain errors or lack needed context, Reuters does not guarantee the accuracy of the translated text, which is provided for reader convenience only. Reuters accepts no liability for any damage or loss caused by the use of automated translation functions.)